Truda Gabriella, Howells Sarah, Berry Madeleine, Al-Shurbasi Nour
Department of Breast, Plastic and Reconstructive Surgery, Royal Hallamshire Hospital, Sheffield, GBR.
Department of Breast Screening and Breast Imaging, Royal Hallamshire Hospital, Sheffield, GBR.
Cureus. 2024 Dec 26;16(12):e76406. doi: 10.7759/cureus.76406. eCollection 2024 Dec.
Background The incidence of margin re-excision following breast conserving surgery (BCS) is a quality measure in the National Health Service. The threshold is less than 20% of all BCS procedures. Despite three decades of studies and a wealth of literature identifying multiple factors associated with increased risk for margin involvement, an accepted threshold rate affecting one in five procedures remains high. Aim The aim of the study was to identify adverse features that continue to compromise successful margin clearance despite the recognition of risk factors and the implementation of strategies designed to minimise those risks. Methods All margin re-excisions following BCS for invasive breast carcinoma and ductal carcinoma in situ (DCIS) performed from October 2013 to September 2018 were retrieved from the database of a single institution. A total of 1379 patients underwent BCS during the period considered, 194 of which needed margin re-excision. Radiological investigations and histopathology reports for each patient were retrieved. Lesion size and focality on mammogram, ultrasound (US) scan, and magnetic resonance imaging (MRI), and histopathologic tumour characteristics were recorded and analysed. Results The overall re-excision rate was 14.06% (194/1379 patients). Margin re-excisions cleared 69% (134/194) of wide local excision cavities that had at least one involved margin. 53% (103/194) of patients had no further disease after one attempt at re-excision and 15.9% (31/of 194) had further disease, which was cleared after re-excision. Another 15.9% (31/194) had disease within the shave with involved margins. In this sub-group the presence of DCIS at the new resection margin accounted for 90.3% (28/31) of cases, 3% (1/31) were invasive ductal carcinoma (IDC) and 6% (2/31) were unrecorded. In the sub-group of patients who had an excised margin with pathology and a new clear margin (15.9% of all re-excisions), DCIS was found in 61% (19/31) of cases, IDC in 12.9% (4/31), invasive lobular carcinoma (ILC) in 6% (2/31) of cases, lobular neoplasia (LN) in 12.9% (4/31), mixed IDC and DCIS in 6% (2/31)of cases. The correlation between imaging size and actual histopathological size has shown a statistically significant discrepancy in this cohort. The median size on histology was 22 mm, compared to a median size of 16 mm on mammography, 14 mm on ultrasound, and 17 mm on MRI. Conclusion According to our cohort of patients, the most consistent factor associated with a re-excision was the presence of DCIS at the resection margin, whether pure DCIS or IDC admixed with DCIS. The comparison between tumour size on imaging and final histopathological size revealed the best correlation with mammogram followed by US. The weakest correlation was with MRI.
保乳手术(BCS)后切缘再次切除的发生率是英国国家医疗服务体系中的一项质量指标。该阈值为所有BCS手术的比例低于20%。尽管经过三十年的研究以及大量文献确定了与切缘受累风险增加相关的多种因素,但影响五分之一手术的公认阈值率仍然很高。
本研究的目的是确定尽管已识别出风险因素并实施了旨在最小化这些风险的策略,但仍继续影响切缘成功清除的不良特征。
从单个机构的数据库中检索2013年10月至2018年9月期间因浸润性乳腺癌和原位导管癌(DCIS)行BCS后进行的所有切缘再次切除病例。在此期间,共有1379例患者接受了BCS,其中194例需要进行切缘再次切除。检索了每位患者的影像学检查和组织病理学报告。记录并分析了乳房X线摄影、超声(US)扫描和磁共振成像(MRI)上的病变大小和灶性,以及组织病理学肿瘤特征。
总体再次切除率为14.06%(194/1379例患者)。切缘再次切除清除了69%(134/194)至少有一个受累切缘的广泛局部切除腔。53%(103/194)的患者在一次再次切除尝试后无进一步疾病,15.9%(31/194)有进一步疾病,经再次切除后清除。另有15.9%(31/194)在切缘受累的剃须切除范围内有疾病。在该亚组中,新切除切缘处存在DCIS占病例的90.3%(28/31),3%(1/31)为浸润性导管癌(IDC),6%(2/31)未记录。在有病理切缘且新切缘清晰的患者亚组中(占所有再次切除的15.9%),61%(19/31)的病例发现DCIS,12.9%(4/31)为IDC,6%(2/31)为浸润性小叶癌(ILC),12.9%(4/31)为小叶瘤变(LN),6%(2/31)为IDC和DCIS混合。在该队列中,影像学大小与实际组织病理学大小之间的相关性显示出统计学上的显著差异。组织学上的中位大小为22mm,而乳房X线摄影上的中位大小为16mm,超声上为14mm,MRI上为17mm。
根据我们的患者队列,与再次切除最一致相关的因素是切除切缘处存在DCIS,无论是单纯DCIS还是与DCIS混合的IDC。影像学上的肿瘤大小与最终组织病理学大小之间的比较显示,与乳房X线摄影的相关性最好,其次是US。与MRI的相关性最弱。